Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

The third ultra-high-yield dividend stock that makes for a no-brainer buy in August is none other than the premier retail ...

Pfizer Inc. reports its Q2 earnings soon, carrying the weight of a 10% stock dip this year. The company, known for its ...

Markets are trying hard to see the bright side of bad news in the United States, anticipating dour data will trigger the ...

Newcomers will not only be plugging into UPS while its forward-looking yield stands at 7.4%, but while the stock's priced dirt cheap -- at only 13 times this year's analyst-expected per-share earnings ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

President Trump's executive order to "identify and take appropriate action to correct past misconduct by the Federal Government related to censorship of protected speech" is good enough, DOJ tells ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The firm will continue developing Lava's two partnered bispecific gamma delta T-cell engager programs with Pfizer and Johnson & Johnson.

The drug maker reports second-quarter earnings Tuesday, and investors continue to eye a list of glaring problems.

Estimate trends have been broadly positive heading into the print: EPS estimates have seen 7 upward revisions and 3 downward over the past 90 days. Revenue estimates have been revised upward 8 times, ...

The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...